These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 21440102)

  • 1. [Potential of liposomes for the intravitreal injection of therapeutic molecules].
    Bochot A; Lajavardi L; Camelo S; Bourges JL; Behar-Cohen F; de Kozak Y; Fattal E
    Ann Pharm Fr; 2011 Mar; 69(2):100-7. PubMed ID: 21440102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes for intravitreal drug delivery: a state of the art.
    Bochot A; Fattal E
    J Control Release; 2012 Jul; 161(2):628-34. PubMed ID: 22289436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to the posterior segment of the eye.
    Thrimawithana TR; Young S; Bunt CR; Green C; Alany RG
    Drug Discov Today; 2011 Mar; 16(5-6):270-7. PubMed ID: 21167306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical devices for the treatment of eye diseases.
    Yasukawa T; Ogura Y
    Handb Exp Pharmacol; 2010; (197):469-89. PubMed ID: 20217540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration.
    Claro C; Ruiz R; Cordero E; Pastor MT; López-Cortés LF; Jiménez-Castellanos M; Lucero M
    Exp Eye Res; 2009 Mar; 88(3):528-34. PubMed ID: 19084004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.
    Myles ME; Neumann DM; Hill JM
    Adv Drug Deliv Rev; 2005 Dec; 57(14):2063-79. PubMed ID: 16310884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations.
    Short BG
    Toxicol Pathol; 2008 Jan; 36(1):49-62. PubMed ID: 18337221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.
    Bochot A; Fattal E; Boutet V; Deverre JR; Jeanny JC; Chacun H; Couvreur P
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):253-9. PubMed ID: 11773039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug delivery systems for vitreoretinal diseases.
    Yasukawa T; Ogura Y; Tabata Y; Kimura H; Wiedemann P; Honda Y
    Prog Retin Eye Res; 2004 May; 23(3):253-81. PubMed ID: 15177203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotherapy for posterior eye diseases.
    Kaur IP; Kakkar S
    J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of liposomes as intravitreal drug delivery system].
    Bejjani RA; Jeanny JC; Bochot A; Behar-Cohen F
    J Fr Ophtalmol; 2003 Nov; 26(9):981-5. PubMed ID: 14631286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel drug delivery systems for retinal diseases. A review.
    Lee SS; Robinson MR
    Ophthalmic Res; 2009; 41(3):124-35. PubMed ID: 19321933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
    Jonas JB; Kreissig I; Degenring R
    Prog Retin Eye Res; 2005 Sep; 24(5):587-611. PubMed ID: 16005407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periocular routes for retinal drug delivery.
    Raghava S; Hammond M; Kompella UB
    Expert Opin Drug Deliv; 2004 Nov; 1(1):99-114. PubMed ID: 16296723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal drug therapy.
    Peyman GA; Schulman JA
    Jpn J Ophthalmol; 1989; 33(4):392-404. PubMed ID: 2696799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance and localization of intravitreal liposomes in the aphakic vitrectomized eye.
    Stern WH; Heath TD; Lewis GP; Guerin CJ; Erickson PA; Lopez NG; Hong KL
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):907-11. PubMed ID: 3032840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes.
    Zhang R; He R; Qian J; Guo J; Xue K; Yuan YF
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3575-82. PubMed ID: 20164461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.